West Pharmaceutical names new CEO; Evoke meets FDA manufacturing requirement;

> West Pharmaceutical Services ($WST) has named Eric Green as its new chief executive officer, replacing Donald Morel, Jr. Announcement

> The FDA continues to work with the Chinese government on visas to get more regulatory agency inspectors on the ground. Article

> Solana Beach, CA-abased Evoke Pharma ($EVOK) says it has met the FDA requirement of producing its gastrointestinal drug candidate to commercial scale. Release

> U.K.-based Juniper Pharma Services has won permission from U.K. regulator MHRA to manufacture and supply bulk unlicensed medicines. Report

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

Pricing controversies shouldn't overshadow Phlow's promise to provide low-cost drugs to address COVID-19, says the CEO of partner Civica Rx.